Pineal peptides restore the age-related disturbances in hormonal functions of the pineal gland and the pancreas.
Level 5 - mechanism / opinion, no new human data
Animal research (non-human primates)
PubMed 15664732 · doi:10.1016/j.exger.2004.10.004
What was done
Researchers evaluated pineal and pancreatic endocrine function in young (6-8 years) versus old (20-27 years) rhesus monkeys, and assessed the effects of epitalon, a synthetic analogue of epithalamin. Basal glucose, insulin, and nighttime melatonin levels were measured, alongside glucose and insulin responses during a glucose administration test, before and after epitalon administration in both age groups.
What was found
Compared to young monkeys, old monkeys showed higher basal plasma glucose and insulin, lower nighttime melatonin, a larger glucose response area under the curve, a reduced glucose disappearance rate, and a reduced 5-minute insulin peak. In old monkeys, epitalon administration decreased basal glucose and insulin, increased basal nighttime melatonin, reduced glucose area under the curve, increased glucose disappearance rate, and normalized insulin dynamics. Epitalon produced no hormonal or metabolic changes in young monkeys. The abstract reports no numerical values or statistical estimates.
Why it matters
The study suggests synthetic pineal peptides can reverse age-associated impairments in glucose tolerance and melatonin secretion in non-human primates.
Limits
The abstract lacks sample sizes, specific drug dosages, treatment durations, and exact numerical or statistical values. As an animal study in rhesus monkeys, findings cannot be directly applied to humans without clinical trial validation.
Cited by
- partial Epithalon shows benefits in healing parts of the brain associated with regulating the circadian rhythm.